SupremeCourt

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Wednesday, October 3, 2012

NBA set to prosecute Monsanto’s Indian subsidiary: What about Cornell, USAID & the DBT?

Posted on 5:26 PM by Unknown
In a story which ran today on PTI, the Chairperson of the National Biodiversity Authority (NBA) has reportedly informed the press that his organization is all set to prosecute Monsanto’s Indian subsidiary (Mahyco) in a criminal court for violation of India’s Biological Diversity Act, when Mahyco allegedly accessed ‘germ-plasm’ related to certain varieties of brinjal. According to the PTI report the Chairperson states “The company has used local variety of brinjal to develop BT brinjal. We are in the advanced stage of filing a case against companies involved in that. As per the Act it's a criminal case. It is a cognisable offence”. 

I had covered this issue in detail in two previous posts that be accessed over here and here. 

Once again, I would like to reiterate that the NBA does not seem to have any solid ground to proceed with its complaint. The reason for this being that this particular project, for which Mahyco is being charged, is a part of a larger tripartite agreement which has already received the blessings of the Central Government. The agreement to access the germplasm and develop it into a pest resistant variety was entered into by Mahyco with the University of Agricultural Sciences at Dharwad and Sathguru Management Consultants. The agreement can be accessed over here. In this agreement, Sathguru Management Consultants represents itself as the national co-ordinator for the ABSP – II project which is led by Cornell and funded by the United States Agency for International Development (USAID). 

The charges levelled against Mahyco by a NGO, whose complaint has formed the basis of this prosecution, is that Mahyco accessed Indian biological resources without prior permission from the NBA. The Parliamentary Standing Committee on Agriculture in its recently released 37th Report, had castigated the NBA for not moving forward with the prosecution of Mahyco and is likely to have contributed to this decision to move ahead with the filing of the case. 

But does the NBA have a case over here? I don’t think so. Section 5(3)(b) of the Biological Diversity Act is pretty clear that permission from the NBA is not required in collaborative research projects between government sponsored institutions of India and other countries if such projects have been approved by the Central Government. UAS, was a government university. The entire ABSP – II project is a part of the Knowledge Initiative on Agriculture (KIA) entered into between the Governments of India and the U.S. In fact going by the submissions from Mahyco, the Department of Biotechnology (DBT), Government of India appears to be neck-deep in this project. The letter available on page 13 of this link, is from the DBT to UAS discussing funding etc. Clearly this is adequate proof that the Central Govt. was wholly aware of this project and the fact that it was accepting funding proposals from UAS suggests that it approved of the project. 

So on what basis is the NBA going to launch prosecution? I don’t know. 

Presuming that NBA has the basis to launch a prosecution against Mahyco, it should necessarily prosecute all the parties involved in the project and that would include the competent representatives of Cornell, USAID, University of Agricultural Sciences and the Department of Biotechnology. All these organizations were involved in the project and it should necessarily follow that all of them should share the blame with Mahyco. 

Personally, speaking only on my behalf, I think this entire case is frivolous if not malicious.
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in Biological Diversity, biopiracy, biotech | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • IPAB on Payyannur Ring
    [*S lightly long post] Background: The Intellectual Property Appellate Board (“ IPAB ”), in its recent order in SubhashJewellery v. Payyan...
  • Satyajit Ray's sketches and copyright controversies
    A copyright row appears to have started between the Satyajit Ray Society and the Delhi Art Gallery, that is organising a countrywide exhibit...
  • Ghost Post: Samsung v. Apple Presidential Enforcement Veto
    SpicyIP subscribers recently received a short blurb from Shamnad on this FT article regarding the hypocrisy of stamping 'national inter...
  • Dorling Kindersley v. Sanguine Technical Publishers
    A recent Delhi High Court order passed on 21 January, 2013  with respect to copyright licensing has come to our notice. An analysis of the j...
  • SpicyIP Tidbit: ALCS August Distribution
    In the UK, the Authors' Licensing and Collecting Society is an organization run and owned by writers that collects money due to its mem...
  • Delhi HC rejects the "Hot News" Doctrine: A Summary
    The applicability of the Hot News doctrine was rejected recently in a landmark ruling delivered by Justice Bhat of the Delhi HC. This post i...
  • IP Research Assistant position at IIT, Madras
    Feroz Ali Khader, MHRD IP Chair at the Indian Institute of Technology (IIT) Madras, is looking for research assistants to work on various is...
  • Thalappakatti biryani trademark row
    The southern district of Dindigal in Tamil Nadu occupies a special place in the hearts of biryani lovers. In the late 1950s, one Nagasamy N...
  • SpicyIP Tidbit: GI for Pedana Kalamkari Art Form
    Image from here Recently, as The Hindu reports , Pedana Kalamkari art form received GI protection. Members of Vegetable Dye Hand Block Kalam...
  • Loss of an IP Leader: RIP Prof Daruwalla
    Most in the Indian IP firmament may have heard of the doleful demise of one of our IP leaders, Mr. Tehemtan Nasserwanji Daruwalla. He was an...

Categories

  • 126 (1)
  • 3(d) (4)
  • 3(f) (1)
  • 3(i) (1)
  • 3(k) (2)
  • Academic Writing (1)
  • access (10)
  • access to food (1)
  • access to health (3)
  • AIA (1)
  • AIDS/HIV (3)
  • Antitrust (2)
  • Bajaj v LML (1)
  • Basmati Row (2)
  • Biological Diversity (5)
  • Biologics (2)
  • biopiracy (4)
  • biotech (7)
  • Bollywood (25)
  • Broadcasters Rights (5)
  • Budget (1)
  • business method patent (2)
  • Call for papers (2)
  • Cipla (2)
  • Comparative Advertising (4)
  • Competition law (8)
  • Compulsory Licensing (27)
  • condonation of delay (1)
  • Conference (4)
  • Constitution (12)
  • Contracts (1)
  • Controller's decisions (8)
  • Copyright (112)
  • Copyright Amendment Bill 2010 (23)
  • copyright board (4)
  • Copyright Exceptions (6)
  • copyright office (1)
  • Copyright Rules (2013) (5)
  • Copyright Societies (9)
  • Counterfeiting (1)
  • creativity (1)
  • Cross Retaliation (1)
  • csir (4)
  • d (1)
  • D.U. Photocopy Case (16)
  • Darjeeling Tea (3)
  • Data Exclusivity (2)
  • Database (1)
  • DCGI (2)
  • decompilation (2)
  • defamation (9)
  • Designs (3)
  • Designs Act (3)
  • Differential Pricing (2)
  • Dilution (1)
  • Disabilities (3)
  • Disability (2)
  • DMCA (2)
  • Doha Declaration (1)
  • Domain Names (2)
  • Draft Policy of the Indian Government (2)
  • DRM (1)
  • Drug Regulation (7)
  • education (12)
  • Enercon (1)
  • Enforcement (1)
  • EU (2)
  • ex parte (2)
  • exhaustion (3)
  • Exhaustion of Rights (2)
  • Fair Dealing (8)
  • Fair Use (11)
  • Federal Circuit (1)
  • Fees (3)
  • FICCI (7)
  • FRAND (2)
  • free trade agreement (3)
  • FTA (3)
  • G.I. Registry (4)
  • gene sequences (3)
  • Generic medicine (4)
  • Geographical Indication (14)
  • Gilead (1)
  • Glenmark (5)
  • Gopika (34)
  • Guest post (11)
  • guidelines (1)
  • GWU-CII (1)
  • Herceptin (1)
  • hot news (3)
  • ICANN (1)
  • incremental innovation (1)
  • independence (1)
  • india (5)
  • Indian Government (1)
  • Indian patent litigation (27)
  • Indian Pharma (35)
  • Injunction (10)
  • Innovation (7)
  • INTA (1)
  • Intermediaries (10)
  • internet (11)
  • Internet Access Providers (IAPs) (5)
  • Internet Censorship (7)
  • IP scholarship (3)
  • IP aware (4)
  • IP Course (3)
  • IP Education (1)
  • IP Policy (11)
  • IP update (4)
  • ip writing competition (1)
  • IPAB (34)
  • ipchair (1)
  • IPO (1)
  • IPRS (5)
  • IT Act (1)
  • Journal (2)
  • judicial independence (3)
  • Jurisdiction (1)
  • Kruttika (4)
  • Legal Education (3)
  • Legal Research Tools (1)
  • Legal Scholarship (2)
  • library (2)
  • Licensing (7)
  • Madhulika (20)
  • mathematical methods (1)
  • Media law (3)
  • medical method (1)
  • Merck (4)
  • mhrd ip chair (1)
  • Microsoft (3)
  • Middle Path (1)
  • Moral Rights (2)
  • Movies (18)
  • musical work (2)
  • nanotechnology (1)
  • Natco (3)
  • natco defamation suit (5)
  • natco vs bayer (4)
  • need for transparency (1)
  • Novartis (8)
  • Novartis patent case in India (11)
  • NPEs (2)
  • nujs (1)
  • NUJS Conference (2)
  • Obituary (1)
  • obviousness (7)
  • Off-Topic (2)
  • online course (4)
  • Open Access (6)
  • Open Source (2)
  • Opposition (3)
  • Parallel Imports (4)
  • Parliament (1)
  • passing off (5)
  • Patent (52)
  • Patent act (10)
  • patent agent (5)
  • patent agent exam (9)
  • patent agent exam qualifications (3)
  • patent infringement (5)
  • Patent Licensing (2)
  • Patent litigation (2)
  • Patent Office (19)
  • patent pool (3)
  • Patent Prosecution (7)
  • Patent rules (2)
  • Patent Strategies (8)
  • Patents (9)
  • pegasus (1)
  • Personality Rights (1)
  • Pfizer (1)
  • Pharma (18)
  • Piracy (5)
  • plagiarism (3)
  • Plant Variety Protection (2)
  • post grant (1)
  • Prashant (2)
  • Preventive Detention (1)
  • Price Control (6)
  • prior publication (1)
  • Privacy (3)
  • Prizes (1)
  • public health (3)
  • Public Interest (4)
  • Publicity Rights (4)
  • Publishing (3)
  • radio (2)
  • Rajiv (18)
  • Rectification Petition (2)
  • Rejection (1)
  • research (3)
  • reverse engineering (2)
  • revocation (4)
  • rip (1)
  • Roche (2)
  • Roche vs Cipla (1)
  • Royalty (2)
  • RTI (2)
  • Scholarship (4)
  • section 16 (1)
  • Section 3(d) (7)
  • section 8 (6)
  • shamnad (11)
  • Shan Kohli (4)
  • Shouvik Kumar Guha (30)
  • Smartphones/Tablets (2)
  • Social Innovation (1)
  • Software (10)
  • software enforcement (3)
  • software patent (3)
  • Special 301 Report (1)
  • Spicy Tidbits (6)
  • spicyip (1)
  • SpicyIP Accolades (1)
  • SpicyIP Announcements (9)
  • SpicyIP Case (1)
  • SpicyIP Cases (3)
  • spicyip commiseration (1)
  • SpicyIP Events (11)
  • SpicyIP Fellowship (5)
  • SpicyIP Guest Series (22)
  • SpicyIP Interview (2)
  • SpicyIP Jobs (4)
  • SpicyIP Jobs/General (2)
  • SpicyIP Review (1)
  • SpicyIP Tidbits (11)
  • SpicyIP Weekly Review (27)
  • Statutory Licensing (1)
  • STI Policy 2013 (4)
  • Sugen (3)
  • Supreme Court of India (5)
  • Swaraj (19)
  • Tarnishment (1)
  • Technology (6)
  • Technology Transfer (5)
  • TKDL (5)
  • TPP (1)
  • trade (4)
  • Trade Secret Protection (1)
  • Trademark (59)
  • Trademark dilution (1)
  • Trademark Registry (9)
  • Traditional Knowledge (7)
  • Transparency (5)
  • treaty (1)
  • trial (1)
  • tribunals (2)
  • TRIPS (11)
  • UK (3)
  • unfair competition (5)
  • UNFCCC (1)
  • Universities Research and Innovation Bill (2)
  • US (1)
  • US Patent Reform (1)
  • US Supreme Court (3)
  • viva (3)
  • WIPO (5)
  • Working a Patent (2)
  • Workshop (4)
  • writ (1)
  • WTO (1)

Blog Archive

  • ►  2013 (364)
    • ►  September (13)
    • ►  August (41)
    • ►  July (36)
    • ►  June (36)
    • ►  May (32)
    • ►  April (51)
    • ►  March (66)
    • ►  February (40)
    • ►  January (49)
  • ▼  2012 (131)
    • ►  December (29)
    • ►  November (42)
    • ▼  October (50)
      • 5 Reasons Why Course Packs are Legal in India
      • Academia struggles to pay up as Journal prices soar!
      • First sale doctrine under threat in US
      • Guest Post: Ownership and Assignment of Indian Pat...
      • Supreme Court grants BharatMatrimony stay against ...
      • IP in the multiverse: Law of Superheroes
      • Govt. of India follows up on SpicyIP reporting – r...
      • Karnataka High Court temporarily restrains German ...
      • Copyright Aggression vs Educational Access: The "G...
      • Rebutting arguments against multiple copyright soc...
      • Mapping out the future of Indian copyright societies
      • Add a disclaimer says Supreme Court: Bata has happ...
      • Spicy IP Weekly Review (October Week 3)
      • Delhi University Restrained for Alleged Admission ...
      • Appeal to Publishers to Withdraw Suit Filed agains...
      • September 2012: Controller's decisions at the IPO
      • The ‘Register of Owners’ for future copyright soci...
      • Bata sho(o)ed out of Court - No defamation says De...
      • Sugen’s desperate attempt to save its Sunitinib pa...
      • Internet Fraud: Bogus Open Access Journals
      • Guest Post: Bayer-Natco decision TRIPS Compliant?
      • Guest Post: ‘Xerox’ is not Generic.......Yet?!
      • Spicy IP Weekly Review (October Week 2)
      • Roche vs Cipla: A Patent Disappointment?
      • Ever participated in a clinical trial? Perhaps.
      • An anonymous comment in response to the DU Campaig...
      • A test case for India’s new safe harbour provision...
      • Karnataka High Court quashes Controller General’s ...
      • The perils of selective journalism
      • Defensive Patent Licensing: A way out of the Paten...
      • Delhi High Court seeks to break the Myth of 'Break...
      • DU Photocopy Case: Who's Afraid of Copyright?
      • Guest Post: Exide v. Exide: Too much Exidement?
      • Guest Post: The New India Guidelines on Similar Bi...
      • Intellectual Property Rights: Infringement and Rem...
      • More controversy during appointments to IPAB: Delh...
      • SpicyIP Weekly Review (October Week 1)
      • SC on the new drug policy
      • India signs Nagoya protocol ahead of Hyderabad CBD...
      • WIPO defers PPI observer status
      • The need for iron-clad enforcement of Section 8 di...
      • NBA set to prosecute Monsanto’s Indian subsidiary:...
      • Breaking News: Delhi High Court recognizes interna...
      • Breaking news: Cipla succeeds in revoking Pfizer /...
      • TKDL poised to draw first blood before Indian pate...
      • ICANN set to change the topography of the internet
      • Call for Papers: Christ University, Law Journal
      • A Glass and a Half full of Purple Joy: Cadbury win...
      • EBC granted injunction against Lexis Nexis for inf...
      • Novelty of Design: Tarun Sethi v. Vikas Budhiraja
    • ►  September (10)
Powered by Blogger.